BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23573962)

  • 1. Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats.
    Mendes TC; Antunes F; Trachez MM; Nascimento NM; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):404-11. PubMed ID: 23573962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
    Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic agonists in the treatment of neuropathic pain: a novel finding.
    Deng L; Guindon J
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):395-7. PubMed ID: 23701118
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-emptive intrathecal quinidine alleviates spinal nerve ligation-induced peripheral neuropathic pain.
    Cheng KI; Wang HC; Lai CS; Tsai HP; Kwan AL; Ho ST; Wang JJ; Chang LL
    J Pharm Pharmacol; 2011 Aug; 63(8):1063-9. PubMed ID: 21718290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
    Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain.
    Yogeeswari P; Ragavendran JV; Sriram D; Kavya R; Vanitha K; Neelakantan H
    Pharmacology; 2008; 81(1):21-31. PubMed ID: 17785996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice.
    Saika F; Kiguchi N; Kobayashi Y; Kishioka S
    Acta Physiol (Oxf); 2015 Feb; 213(2):462-71. PubMed ID: 25491757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperalgesic effect of 5-HT7 receptor activation on the midbrain periaqueductal gray in a rat model of neuropathic pain.
    Li SF; Zhang YY; Li YY; Wen S; Xiao Z
    Pharmacol Biochem Behav; 2014 Dec; 127():49-55. PubMed ID: 25450118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.
    Hagenacker T; Schäfer N; Büsselberg D; Schäfers M
    Eur J Pain; 2013 Jul; 17(6):881-92. PubMed ID: 23229998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
    Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
    Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tramadol with minocycline exerted synergistic effects on a rat model of nerve injury-induced neuropathic pain.
    Mei XP; Chen L; Wang W; Wu D; Wang LY; Zhang T; Zhang H; Xu LX; Li YQ
    Neurosignals; 2013; 21(3-4):184-96. PubMed ID: 22964800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
    Lee HG; Park SK; Yoon MH
    Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model.
    He WJ; Cui J; Du L; Zhao YD; Burnstock G; Zhou HD; Ruan HZ
    Behav Brain Res; 2012 Jan; 226(1):163-70. PubMed ID: 21933684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats.
    Kambur O; Männistö PT; Pusa AM; Käenmäki M; Kalso EA; Kontinen VK
    Eur J Pain; 2011 Aug; 15(7):732-40. PubMed ID: 21216640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation.
    Liu Q; Gao X; Wang T; Wang X; Li R; Jiang Y; Ye J
    Brain Res; 2023 Feb; 1800():148187. PubMed ID: 36463957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain.
    Lima CK; Silva RM; Lacerda RB; Santos BL; Silva RV; Amaral LS; Quintas LE; Fraga CA; Barreiro EJ; Guimaraes MZ; Miranda AL
    PLoS One; 2014; 9(6):e99510. PubMed ID: 24941071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
    J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.